Literature DB >> 7410830

Identification of the immunosuppressive components of canine pulmonary surface active material.

M J Ansfield, B J Benson.   

Abstract

Pulmonary surface active material (SAM), purified from canine lung lavage fluids, is a phospholipid-rich lipoprotein with potent immunosuppressive activity. Experiments were performed to identify those components of SAM that were responsible for this immunosuppressive effect. Results indicated that the lipid, and not the protein, fraction of SAM was immunosuppressive. Two phospholipids, phosphatidylglycerol and phosphatidylcholine, were identified as the predominant immunosuppressive components of the SAM-lipid fraction. lymphocyte proliferation in response to mitogenic or allogeneic stimulation was suppressed by intact SAM, SAM-lipid, phosphatidylglycerol, and phosphatidylcholine. Each of these preparations inhibited RNA, protein and DNA synthesis by mitogen-stimulated lymphocytes. Antioxidants consistently failed to diminish the immunosuppressive properties of SAM or its lipid components. The mechanism of this immunosuppressive action of SAM and its phospholipid components remains undefined. Our data indicate, however, that it is unlikely to be due either to cytotoxicity or to an artifact of lipid oxidation in vitro.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7410830

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  The role of surfactant in the pulmonary reaction to mineral particles.

Authors:  A G Heppleston
Journal:  Int J Exp Pathol       Date:  1991-10       Impact factor: 1.925

Review 2.  Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages.

Authors:  P G Holt
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

3.  Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes.

Authors:  M L Wilsher; D A Hughes; P L Haslam
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

4.  Immunomodulatory effects of pulmonary surfactant on natural killer cell and antibody-dependent cytotoxicity.

Authors:  M L Wilsher; D A Hughes; P L Haslam
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

5.  A macrophage-suppressing 40-kD protein in a case of pulmonary alveolar proteinosis.

Authors:  J Müller-Quernheim; R E Schopf; P Benes; V Schulz; R Ferlinz
Journal:  Klin Wochenschr       Date:  1987-10-01

6.  Alveolar type II cell response in rats exposed to aerosols of alpha-cristobalite.

Authors:  R B Low; K O Leslie; D R Hemenway; M Absher; K B Adler; M S Giancola; P M Vacek
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

7.  Expression of hydrophilic surfactant proteins by mesentery cells in rat and man.

Authors:  B Chailley-Heu; S Rubio; J P Rougier; R Ducroc; A M Barlier-Mur; P Ronco; J R Bourbon
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

8.  Immunoregulatory properties of pulmonary surfactant: influence of variations in the phospholipid profile.

Authors:  M L Wilsher; D A Hughes; P L Haslam
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

9.  Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells.

Authors:  L G Dobbs; J R Wright; S Hawgood; R Gonzalez; K Venstrom; J Nellenbogen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

10.  Decreased phosphatidylcholine in the lung fluid of patients with sarcoidosis.

Authors:  R P Baughman; S Strohofer; M Dohn
Journal:  Lipids       Date:  1985-07       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.